MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 69 filers reported holding MIRATI THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 1.11 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,870,008 | +52.1% | 111,800 | +26.2% | 0.00% | +100.0% |
| Q2 2023 | $3,201,118 | -1.0% | 88,600 | +1.8% | 0.00% | 0.0% |
| Q1 2023 | $3,234,660 | -24.1% | 87,000 | -7.4% | 0.00% | -33.3% |
| Q4 2022 | $4,259,140 | -33.9% | 94,000 | +2.0% | 0.00% | -40.0% |
| Q3 2022 | $6,439,000 | +5.1% | 92,200 | +1.0% | 0.01% | +25.0% |
| Q2 2022 | $6,129,000 | -18.4% | 91,300 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $7,507,000 | -35.6% | 91,300 | +14.8% | 0.00% | -42.9% |
| Q4 2021 | $11,662,000 | -17.2% | 79,500 | -0.1% | 0.01% | -22.2% |
| Q3 2021 | $14,082,000 | +11.6% | 79,600 | +1.9% | 0.01% | +12.5% |
| Q2 2021 | $12,615,000 | -8.4% | 78,100 | -2.9% | 0.01% | -11.1% |
| Q1 2021 | $13,773,000 | -4.3% | 80,400 | +22.7% | 0.01% | -10.0% |
| Q4 2020 | $14,386,000 | +34.7% | 65,500 | +1.9% | 0.01% | +25.0% |
| Q3 2020 | $10,677,000 | +48.2% | 64,300 | +1.9% | 0.01% | +33.3% |
| Q2 2020 | $7,204,000 | +88.6% | 63,100 | +27.0% | 0.01% | +50.0% |
| Q1 2020 | $3,820,000 | -39.4% | 49,700 | +1.6% | 0.00% | -33.3% |
| Q4 2019 | $6,301,000 | +84.2% | 48,900 | +11.4% | 0.01% | +50.0% |
| Q3 2019 | $3,420,000 | -22.2% | 43,900 | +2.8% | 0.00% | -20.0% |
| Q2 2019 | $4,398,000 | +68.6% | 42,700 | +19.9% | 0.01% | +66.7% |
| Q1 2019 | $2,609,000 | +79.3% | 35,600 | +3.8% | 0.00% | +50.0% |
| Q4 2018 | $1,455,000 | +2.0% | 34,300 | +13.2% | 0.00% | 0.0% |
| Q3 2018 | $1,427,000 | -4.5% | 30,300 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,494,000 | +974.8% | 30,300 | +44.3% | 0.00% | – |
| Q3 2016 | $139,000 | +20.9% | 21,000 | 0.0% | 0.00% | – |
| Q2 2016 | $115,000 | -73.5% | 21,000 | 0.0% | 0.00% | -100.0% |
| Q1 2016 | $434,000 | -14.7% | 21,000 | +30.4% | 0.00% | 0.0% |
| Q4 2015 | $509,000 | -8.1% | 16,100 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $554,000 | +104.4% | 16,100 | +87.2% | 0.00% | 0.0% |
| Q2 2015 | $271,000 | – | 8,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |